Efficacy and tolerability of coaxil (tianeptine) in the therapy of posttraumatic stress disorder

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 105, Issue 11, 2005, Pages 24-29

  Alexandrovsky, Yu A ^a   Avedisova, A S ^a   Boev, I V ^a   Bukhanovsky, A O ^a   Voloshin, V M ^a   Tsygankov, B D ^a   Shamrey, V K ^a  

^a NONE

Author keywords

Coaxil; Efficacy; Posttraumatic stress disorder (PTSD); Treatment; Treatment tolerability

Indexed keywords

THIAZEPINE DERIVATIVE; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MULTICENTER STUDY; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; THIAZEPINES;

EID: 33644822593     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Costa e Silva J.A. et al. Placebo-controlled study of tianeptine in major depressive episodes. Neuropsychobiology 1997; 35: 1: 24-29.
2. Delbende C., Tranchand-Bunel D., Tarozzo G. et al. Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary- adrenal axis. Eur J Pharmacol 1994; 251: 245-251.
3. Novotny V., Faltus F. Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study. Hum Psychopharmacol 2002; 17: 6: 299-303.
4. Thomas G. Tianeptine in PTSD: a double-blind study versus placebo. Protocol and methodologycal issues. XI World Congress of Psychiatry, August, Hamburg 1999.
5. Waintraub L., Septien L., Azoulay P. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine. CNS Drugs 2002; 16: 1: 65-75.